InvestorsHub Logo
Followers 275
Posts 32783
Boards Moderated 0
Alias Born 11/14/2013

Re: Doc logic post# 663405

Thursday, 01/11/2024 10:47:15 PM

Thursday, January 11, 2024 10:47:15 PM

Post# of 711716
Come on man….

Hoffman was predicting January 3 for acceptance. All of a sudden, once we entered 2024, he’s correcting himself calling it validation and very low chance to be announced.

Something happened.


Senti and BrightBoy said, hold my beer, and claimed validation occurred immediately upon submission. (While it is true, apparently, validation reverts to submission date, validation has not been known to take less than a few days after submission.). But Senti said, end of discussion.

Many people fell in line.

Now smith is repeating same general concept of Validation is simultaneous.

Anyway, Smith goes on to do the same range as Hyperopia. Could be really soon, but odds are July. Smith says 150+ days the likely route but who knows. He definitely, in his mind believes the approval pathway type will not be discussed before approval decision made. He literally made this point three times.

Before removing her linked in, Canadian Power hoped for 150 day, but appropriately cautioned off clock time might be added. Then she said something interesting. She was interested in seeing what new accelerated guidance might be coming out. Think this might have been before Christmas, before the echo chamber.

Another post pointed out SWIFT might be a new pathway. I think Abeta first found general MHRA reference about Swift.

Swift, it turns out, aims to prioritze high impact treatments like cancer vaccines (I kid you not) and AI mental health therapy. Swift can reach approval within as little as 60 days when implemented.

I asked Bard if MHRA might use pilot test cases before fully implementing a new program. It emphatically agreed, and one example it gave was when MHRA ran test cases before fully adopting a pathway to increase device approval speed.

Who knows what pathway is invoked, but it might be fast, no wait, accelerated, umm, or swift.

What we do know is the circulating echo chamber is, don’t announce validation, also won’t announce which pathway, could be really soon but most likely July and Smith Doc and DD almost seem to be licking their chops at retail being decimated by their predicted six month silence treatment — with no intervening affirmations like validation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News